Financhill
Back

Krystal Biotech Quote, Financials, Valuation and Earnings

Krystal Biotech Price Quote

$183.61
-0.03 (0.4%)
(Updated: June 29, 2024 at 6:09 AM ET)

Krystal Biotech Key Stats

Sell
49
Krystal Biotech (KRYS) is a Sell

Day range:
$180.86 - $184.44
52-week range:
$93.95 - $191.78
Dividend yield:
0%
P/E ratio:
470.87
P/S ratio:
0.00
P/B ratio:
6.56%

Volume:
859.5K
Avg. volume:
514K
1-year change:
56.64%
Market cap:
$5.2B
Revenue:
$50.7M
EPS:
$1.88

How Much Does Krystal Biotech Make?

Data Unavailable

Is Krystal Biotech Growing As A Company?

Data Unavailable

Krystal Biotech Stock Price Performance

  • Did Krystal Biotech Stock Go Up Last Month?
    Krystal Biotech share price went up by 15.5% last month
  • Did KRYS's Share Price Rise Over The Last Year?
    KRYS share price rose by 56.64% over the past 1 year

What Is Krystal Biotech 52-Week High & Low?

Krystal Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Krystal Biotech?

  • How Much Debt Does Krystal Biotech Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Krystal Biotech Have?
    Cash and short term investments quarterly total is $538.3M
  • What Is Krystal Biotech’s Book Value Per Share?
    Book value per share is 28.02

Is Krystal Biotech Cash Flow Positive?

  • What Is KRYS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$46.8M
  • What Is Krystal Biotech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $211.9M
  • What Is Krystal Biotech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $53.1M

Krystal Biotech Return On Invested Capital

Data Unavailable

Krystal Biotech Earnings Date & Stock Price

Krystal Biotech Competitors

  • Who Are Krystal Biotech's Competitors?
    Below is a list of companies who compete with Krystal Biotech or are related in some way:
    • Agios Pharmaceuticals Inc (AGIO)
    • Biomarin Pharmaceutical Inc (BMRN)
    • Integra Lifesciences Holdings Corp (IART)
    • Madrigal Pharmaceuticals Inc (MDGL)
    • OraSure Technologies Inc (OSUR)

Krystal Biotech Dividend Yield

Data Unavailable

Krystal Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 58.14%
Revenue: 0% -4.47%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 189.00
Upside from Last Price: 2.92%

Major Shareholders

  • How many KRYS shares are owned by institutional investors?
    42M KRYS shares are owned by institutional investors
  • How many KRYS shares are owned by insiders?
    3.5M KRYS shares are owned by insiders